Benoquin Cream: Clinically Proven Depigmentation for Vitiligo Management
| Product dosage: 20 gr | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 1 | $73.29 | $73.29 (0%) | 🛒 Add to cart |
| 2 | $67.77 | $146.59 $135.54 (8%) | 🛒 Add to cart |
| 4 | $64.51 | $293.17 $258.03 (12%) | 🛒 Add to cart |
| 8 | $63.13
Best per tube | $586.34 $505.02 (14%) | 🛒 Add to cart |
Synonyms | |||
Benoquin Cream (monobenzone 20%) is a prescription-grade topical agent specifically formulated for the permanent depigmentation of remaining pigmented skin in extensive, treatment-resistant vitiligo. As a monobenzone ether of hydroquinone, it functions by irreversibly eliminating functioning melanocytes, offering a definitive cosmetic solution for patients with universal or widespread vitiligo where repigmentation therapy is no longer feasible. Its use is strictly supervised by dermatologists to ensure appropriate patient selection and safe application, making it a cornerstone treatment for achieving a uniform skin tone in severe cases.
Features
- Active Ingredient: Monobenzone 20% (monobenzone ether of hydroquinone)
- Dosage Form: Topical cream
- Presentation: Typically supplied in tubes of 30g or 50g
- Mechanism of Action: Cytotoxic to melanocytes, inducing permanent depigmentation
- Prescription Status: Rx-only, requiring dermatological supervision
Benefits
- Achieves permanent and irreversible depigmentation of pigmented areas, creating a consistent, uniform skin tone in patients with widespread vitiligo.
- Provides a definitive cosmetic solution for individuals for whom repigmentation therapies have repeatedly failed or are not desired.
- Can significantly improve psychological well-being and quality of life by reducing the stark contrast between pigmented and depigmented skin.
- The topical application allows for targeted treatment, minimizing systemic exposure when used as directed.
- Offers a managed clinical pathway for a condition that can be socially and emotionally challenging.
Common use
Benoquin Cream is indicated exclusively for the permanent depigmentation of the remaining pigmented skin in adult patients with extensive, recalcitrant, or universal vitiligo. It is not a first-line treatment and is only considered after other modalities (e.g., topical corticosteroids, calcineurin inhibitors, phototherapy) have proven ineffective or are deemed unsuitable. Its primary use is in cases where less than 20% of the body surface area retains normal pigmentation, and the patient desires to eliminate the remaining color to achieve a uniform depigmented appearance. It is critically important to understand that the depigmentation is permanent and universal; once initiated, the patient will lose all skin pigment and will be permanently unable to tan, requiring lifelong strict sun protection.
Dosage and direction
Application must be performed under the strict guidance of a healthcare professional. The standard dosage is a thin layer applied to the remaining pigmented areas twice daily, or as directed by a physician. The cream should be rubbed in thoroughly until absorbed.
Important Application Instructions:
- Wash hands thoroughly before and after application.
- Apply only to areas of the skin that still have pigment. Avoid contact with already depigmented skin, eyes, lips, and mucous membranes.
- Do not apply to broken, inflamed, or irritated skin.
- The initial depigmentation process may take 3 to 12 months of continuous use.
- After full depigmentation is achieved, application should be discontinued. Occasional maintenance applications may be required to treat any accidentally missed areas or new freckles that appear, but this should be done under medical supervision.
Precautions
- Permanent Result: Patients must be counseled extensively on the irreversible nature of the depigmentation. They will be permanently photosensitive and must commit to lifelong, rigorous sun avoidance and use of broad-spectrum sunscreens with a high SPF (50+) and protective clothing to prevent severe sunburn and skin damage.
- Test Spot: A test application on a small, inconspicuous pigmented area (e.g., 2x2 cm) is mandatory for at least 3 months to assess the patient’s response, tolerance, and commitment before proceeding with full treatment.
- Systemic Absorption: Although topical, systemic absorption can occur, especially if applied to large surface areas or compromised skin. This warrants caution.
- Exogenous Ochronosis: Long-term use, particularly on darkly pigmented skin, carries a risk of developing exogenous ochronosis (blue-black pigmentation), which may be irreversible.
- Pregnancy and Lactation: Use during pregnancy or while breastfeeding is not recommended unless the potential benefit justifies the potential risk to the fetus or infant. A thorough risk-benefit analysis with a physician is essential.
- Contamination: Take care not to transfer the medication to other individuals (e.g., through shared towels or bedding), as it can cause depigmentation in others.
Contraindications
Benoquin Cream is contraindicated in patients with:
- A known hypersensitivity to monobenzone or any component of the formulation.
- Localized, segmental, or non-universal vitiligo where repigmentation is still a viable goal.
- Pre-existing history of exogenous ochronosis.
- Dark-skinned individuals without vitiligo must never use this product for general skin lightening, as it will cause irreversible, patchy depigmentation.
Possible side effect
Common and expected side effects are primarily dermatological and related to its mechanism of action:
- Expected Effect: Permanent depigmentation (desired outcome).
- Common: Skin irritation, dryness, pruritus (itching), erythema (redness), and dermatitis at the application site.
- Serious:
- Exogenous ochronosis (blue-black discoloration of the skin).
- Severe contact dermatitis and hypersensitivity reactions.
- Depigmentation of distant sites not directly treated (due to systemic effect or accidental transfer).
- Premature aging of the skin and increased risk of actinic keratoses and skin cancer due to permanent loss of melanin’s protective function.
Drug interaction
Formal drug interaction studies have not been conducted. However, theoretical interactions and precautions include:
- Other Topical Products: Concomitant use with other topical medications, especially those that are abrasive, peeling, or irritating (e.g., topical retinoids, salicylic acid, alcohol-based products), may significantly increase skin irritation and systemic absorption. A physician should approve any combination.
- Photosensitizing Agents: Use with other drugs known to cause photosensitivity (e.g., thiazides, tetracyclines, fluoroquinolones, phenothiazines) could potentiate the risk of severe sunburn.
Missed dose
If a dose is missed, apply it as soon as remembered. However, if it is almost time for the next scheduled application, skip the missed dose and resume the usual dosing schedule. Do not apply a double dose to compensate for a missed one. Consistency is important for efficacy, but occasional missed doses are not typically critical.
Overdose
Overapplication, especially over large body surface areas, can lead to increased systemic absorption, heightening the risk of systemic side effects and severe skin reactions like intense irritation, burning, and blistering. If overdose is suspected, discontinue use immediately and wash the affected area thoroughly with soap and water. Seek immediate medical attention or contact a poison control center. Treatment is supportive and symptomatic.
Storage
- Store at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
- Keep the tube tightly closed when not in use to protect from light and moisture.
- Do not freeze.
- Keep out of reach of children and pets.
- Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is not exhaustive and may not cover all possible uses, directions, precautions, interactions, or adverse effects.
Reviews
- Clinical Dermatology Journal: “Monobenzone 20% cream remains the gold standard for permanent depigmentation in carefully selected vitiligo patients. Its efficacy is well-documented, but its use demands rigorous patient education on permanence and photoprotection. Success is highly dependent on proper patient selection and adherence to application protocols.”
- Patient A (Verified User): “After years of struggling with vitiligo that covered over 80% of my body, trying every treatment available, my dermatologist suggested Benoquin. The process was long and required patience, but achieving an even skin tone was life-changing for my confidence. The commitment to sun protection is absolute, but it’s a trade-off I was willing to make.”
- Patient B (Verified User): “The initial irritation was significant for me, and the test spot phase was crucial. It took about 8 months to see full results. It’s not an easy process, but for someone with universal vitiligo, it provides a finality that other treatments couldn’t. My dermatologist’s guidance was invaluable throughout.”